NASDAQ NMS - GLOBAL MARKET · SERA
+0.72% · +$0.0200 · Vol 89.1K
Market closed · last close 4:00 PM ET · price as of 16:00:53 ET
Sera Prognostics Inc

Sera Prognostics Inc

Biotechnology
$2.08
Card
Relationship Map

Follow $SERA

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $SERA by email

Veridion Score

BETALOW CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
SERA
Sera Prognostics Inc
Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · LOW confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5 of 6 factors measured · Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is SERA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading SERA catalysts
About Sera Prognostics Inc
SERVICES-MEDICAL LABORATORIES
Listed since
2021
Employees
72
Country
US

Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.07
Day high
$2.16
Day low
$2.07
Previous close
$2.07
52W high
$3.75
-44.40% from high
52W low
$1.59
23% of range
Market cap
$82.3M
EPS
$-0.6700
Beta
0.09
Shares out
39.4M
Volume
89.1K
3.18× rel vol
Avg volume
28K
VWAP
$2.10
Price history computed in-house
1W
+2.71%
1M
-0.71%
3M
+19.14%
1Y
-36.82%
YTD
-29.32%
SMA 50 $2.05 · above
SMA 200 $2.32 · below
52W position 23%

SERA overview

Veridion Score
59
Registered · 2026-09-18
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around SERA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading SERA Form 4 filings
Public disclosures

Congress activity in SERA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for SERA in the cached public ledger.

Federal contracts

SERA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for SERA in this window.
Lobbying spend

SERA lobbying filings, year to date.

Registered lobbying filings matched to Sera Prognostics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for SERA in this window.
Loading news for SERA
Analyst ratings
Sovereign unlock shows live analyst consensus for SERA.
Options
Sovereign unlock shows live options positioning for SERA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.